Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

151.20 -7.64 (-4.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,266,391
Open 157.73
Bid (Size) 151.90 (2)
Ask (Size) 154.00 (2)
Prev. Close 158.84
Today's Range 150.15 - 159.44
52wk Range 121.32 - 464.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Morning Brief: Top Financial Stories Dominating on Monday, May 16
CNBC Volkswagen CEO Shares Ambitious EV Ambitions For US Market 
Via Benzinga
Pfizer/BioNTech COVID-19 Vaccine's European Delivery Takes Backseat To Help Booster Campaign
 
Via Benzinga

Performance

YTD
-34.79%
-34.79%
1 Month
-5.25%
-5.25%
3 Month
-2.15%
-2.15%
6 Month
-39.64%
-39.64%
1 Year
-23.75%
-23.75%

More News

Read More
Johnson & Johnson Stock: A Rare Bright Spot in the Market
Via InvestorPlace
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
Via Benzinga
Where BioNTech Stands With Analysts
Via Benzinga
Why BioNTech Stock Is Rising Today
Via Benzinga
BioNTech Clocks Over $6B In Q1 Sales, Sticks To FY22 Guidance
Via Benzinga
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
Via Benzinga
Stock Market Tries To Bounce From Fresh 2022 Lows; Tesla CEO Elon Musk Puts Twitter Deal 'On Hold': Weekly Review
Via Investor's Business Daily
Cboe's Weekly Market Recap: May 2nd To May 6th
Via Benzinga
Recap: BioNTech Q1 Earnings
Via Benzinga
Should Biotech Be On The Critical List?
Via Talk Markets
Novavax's 22% Post-Earnings Plunge: 5 Factors That Took Toll
Via Benzinga
BNTX Stock Treks Higher on BioNTech’s Vaccine Sales
Via InvestorPlace
Cash Appears To Be King As Investors Sell Stocks, Bonds, And Commodities
Via Benzinga
BioNTech's Revenue Triples On Omicron Demand For Its Pfizer-Partnered Covid Shot
Via Investor's Business Daily
Palantir, Plug Power, Novavax, BioNTech, Lordstown: 5 Key Earnings To Watch Today
Via Benzinga
5 Stocks To Watch For May 9, 2022
Via Benzinga
Bulls Look To Bounce Back After Bear Barrage
Via Benzinga
S&P 500 and Dow Lose 3% While Nasdaq Composite Slides 5%
Via Benzinga
FDA Limits Use of Johnson & Johnson's COVID-19 Vaccine to Certain Individuals - All You Should Know
Via Benzinga
7 Dividend-Paying Large-Cap Stocks to Buy in May
Via InvestorPlace
Arcturus Reports Three-Month Durability Results From ARCT-154 COVID-19 Booster Trial
Via Benzinga
Textbook Company's Results Show Students Are Hitting The Job Market Instead Of The Books
Via Benzinga
US Study Shows Omicron As Severe As Previous COVID Variants: Reuters
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.